Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.07 CHF | +0.81% | +5.64% | +9.66% |
01:37pm | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
May. 10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.66% | 208B | |
+30.09% | 684B | |
+30.34% | 568B | |
-3.62% | 361B | |
+18.45% | 329B | |
+4.12% | 284B | |
+16.21% | 240B | |
-6.83% | 200B | |
+7.00% | 166B | |
-1.23% | 159B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Transcript : Novartis AG, Q3 2022 Earnings Call, Oct 25, 2022